Clinical trial
A Single Centre, Pilot Trial of YF476 in Patients With Chronic Atrophic Gastritis, Hypergastrinaemia and Type I Gastric Carcinoids
NCT01339169 is registered in ClinicalTrials.gov with Trio Medicines Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single Centre, Pilot Trial of YF476 in Patients With Chronic Atrophic Gastritis, Hypergastrinaemia and Type I Gastric Carcinoids
- Lead sponsor
- Trio Medicines Ltd.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 4, 2011
- Completion date
- December 10, 2013
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic atrophic gastritis, hypergastrinaemia, type i gastric carcinoids